This may also delay treatment of concurrent hypogonadism due to wish to preserve open epiphyses in growth hormone-deficient patients not yet on GH, and as mentioned above, timing of puberty or pubertal hormone replacement may affect overall peak bone mass. Here, GH1 is linked to hypogonadism.